Testing a Primary and a Secondary Endpoint in a Group Sequential Design
From MaRDI portal
Recommendations
- A gatekeeping procedure to test a primary and a secondary endpoint in a group sequential design with multiple interim looks
- Design and Analysis of Group Sequential Clinical Trials with Multiple Primary Endpoints
- Improved two-stage group sequential procedures for testing a secondary endpoint after the primary endpoint achieves significance
- Testing Secondary Hypotheses Following Sequential Clinical Trials
- Two-stage group sequential designs for comparative clinical trials
- Closed Testing Procedures for Group Sequential Clinical Trials with Multiple Endpoints
- Tests and confidence intervals for secondary endpoints in sequential clinical trials
Cites work
- Approximately Optimal One-Parameter Boundaries for Group Sequential Trials
- Closed Testing Procedures for Group Sequential Clinical Trials with Multiple Endpoints
- Discrete Sequential Boundaries for Clinical Trials
- Group Sequential Tests for Bivariate Response: Interim Analyses of Clinical Trials with Both Efficacy and Safety Endpoints
- scientific article; zbMATH DE number 1348603 (Why is no real title available?)
- On closed testing procedures with special reference to ordered analysis of variance
- P Values Maximized Over a Confidence Set for the Nuisance Parameter
Cited in
(22)- Sequential tests controlling generalized familywise error rates
- Refined critical boundary with enhanced statistical power for non-directional two-sided tests in group sequential designs with multiple endpoints
- Group-sequential logrank methods for trial designs using bivariate non-competing event-time outcomes
- Comparison of design strategies for a three-arm clinical trial with time-to-event endpoint: power, time-to-analysis, and operational aspects
- Allocating recycled significance levels in group sequential procedures for multiple endpoints
- A gatekeeping procedure to test a primary and a secondary endpoint in a group sequential design with multiple interim looks
- Design and Analysis of Group Sequential Clinical Trials with Multiple Primary Endpoints
- Step-up and step-down methods for testing multiple hypotheses in sequential experiments
- Multiple comparisons in complex clinical trial designs
- Improved two-stage group sequential procedures for testing a secondary endpoint after the primary endpoint achieves significance
- Interim evaluation of efficacy or futility in group‐sequential trials with multiple co‐primary endpoints
- A Note on Familywise Error Rate for a Primary and Secondary Endpoint
- Sample size optimization and initial allocation of the significance levels in group sequential trials with multiple endpoints
- Familywise error for multiple time-to-event endpoints in a group sequential design
- Group sequential Holm and Hochberg procedures
- An order restricted multi-arm multi-stage clinical trial design
- Hierarchical nested trial design (HNTD) for demonstrating treatment efficacy of new antibacterial drugs in patient populations with emerging bacterial resistance
- Multi-arm group sequential designs with a simultaneous stopping rule
- Sample size determination in group-sequential clinical trials with two co-primary endpoints
- A group sequential Holm procedure with multiple primary endpoints
- Testing one primary and two secondary endpoints in a two-stage group sequential trial with extensions
- Interim analysis in sequential multiple assignment randomized trials for survival outcomes
This page was built for publication: Testing a Primary and a Secondary Endpoint in a Group Sequential Design
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3076047)
